Torsade De Pointes-Risk Drugs has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Dolutegravir Sodium And Rilpivirine Hydrochloride. Patients taking Torsade De Pointes-Risk Drugs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Torsade De Pointes-Risk Drugs + Dolutegravir Sodium And Rilpivirine Hydrochloride— Consider alternatives to prescribing JULUCA with drugs with known risk of Torsade de Pointes due to potential additive Q…